KDEV.ST
Karolinska Development AB
Price:  
1.11 
SEK
Volume:  
1,107,905.00
Sweden | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KDEV.ST EV/EBITDA

-138.0%
Upside

As of 2024-12-12, the EV/EBITDA ratio of Karolinska Development AB (KDEV.ST) is -11.32. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KDEV.ST's latest enterprise value is 250.09 mil SEK. KDEV.ST's TTM EBITDA according to its financial statements is -22.08 mil SEK. Dividing these 2 quantities gives us the above KDEV.ST EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 3.9x - 11.0x 7.4x
Forward P/E multiples 5.3x - 9.1x 7.1x
Fair Price (0.26) - (0.57) (0.42)
Upside -123.5% - -151.5% -138.0%
1.11 SEK
Stock Price
(0.42) SEK
Fair Price

KDEV.ST EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-12-02 -10.69
2024-11-29 -10.91
2024-11-28 -10.96
2024-11-27 -10.82
2024-11-26 -10.67
2024-11-25 -10.38
2024-11-22 -10.48
2024-11-21 -10.99
2024-11-20 -11.78
2024-11-19 -11.86
2024-11-18 -11.45
2024-11-15 -9.97
2024-11-14 -11.11
2024-11-13 -10.65
2024-11-12 -10.86
2024-11-11 -11.52
2024-11-08 -12.00
2024-11-07 -12.49
2024-11-06 -12.12
2024-11-05 -12.17
2024-11-04 -12.24
2024-11-01 -12.46
2024-10-31 -12.51
2024-10-30 -12.49
2024-10-29 -12.46
2024-10-28 -12.58
2024-10-25 -12.92
2024-10-24 -12.20
2024-10-23 -12.36
2024-10-22 -12.75
2024-10-21 -13.60
2024-10-18 -13.31
2024-10-17 -12.68
2024-10-16 -12.61
2024-10-15 -12.32
2024-10-14 -12.36
2024-10-11 -12.34
2024-10-10 -12.27
2024-10-09 -12.39
2024-10-08 -12.05
2024-10-07 -12.22
2024-10-04 -12.53
2024-10-03 -12.41
2024-10-02 -12.27
2024-10-01 -12.20
2024-09-30 -12.39
2024-09-27 -12.03
2024-09-26 -12.15
2024-09-25 -12.39
2024-09-24 -12.73